Dr. Saradha Chexal, MD

Dr. Chexal practices at Dell Seton Medical Center at The University of Texas in Austin, Texas, part of Ascension Health Alliance.

Dr. Chexal's NPI, 1013258730, was assigned on March 5, 2013. Dr. Chexal graduated from New York Medical College in 2009. Dr. Chexal holds Texas license Q0890.

Dr. Chexal's primary practice is Dell Seton Medical Center at the University of Texas, at 601 E 15th Street, Austin, TX 78701 in Travis County. The practice phone is (512) 324-7000. Dr. Chexal also practices at Dell Seton Medical Center at University of Texas, 1500 Red River St, Austin, TX 78701.

Dr. Chexal's primary practice is Dell Seton Medical Center at The University of Texas in Austin, Texas, part of Ascension Health Alliance. Dmand AI also links Dr. Chexal to 2 group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chexal practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chexal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chexal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chexal's licenses on file in 2 states: Texas and California.

Dmand AI lists age-related macular degeneration, inflammation of iris, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, surgical retina and vitreous procedures, vision problems and visual impairment and blindness among the conditions Dr. Chexal treats.

CMS data shows 19,016 Medicare services from Dr. Chexal across 15 procedure codes in 2024, for 613 Medicare patients. Medicare paid $1,134,690 for them.

CMS counts 613 Medicare patients who saw Dr. Chexal in 2024. The largest group is 65 to 74, with 280 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chexal's median patient age at 69, with 56% women.

In 2024, Dr. Chexal wrote 212 Medicare Part D claims for 83 patients. 51% of them were for generic drugs. CMS names the drug for 184 of them, across 6 drugs with 11 or more claims each, at $4,573 in total drug cost. In 2023, CMS named 171 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chexal for performance year 2024, reported as part of a group. Dr. Chexal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Chexal to 1 clinical trial. Open Payments lists research payments to Dr. Chexal that name 1 trial.

CMS Open Payments shows 270 general payments to Dr. Chexal from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $14,314. It also lists 7 research payments totaling $2,577 from 2016 to 2017, naming 1 clinical trial.

Dr. Chexal graduated from New York Medical College in 2009.

Dr. Chexal is in network with 22 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.